Fri.Mar 15, 2019

Techstars Foundation Opens Grant Applications From Nonprofits


The Techstars Foundation , the nonprofit arm of startup accelerator operator Techstars which is focused on increasing the number of under-represented entrepreneurs in the technology industry, is looking to give $10,000 to $50,000 to nonprofits working in the area, Techstars said Friday.

Investment in Technology and Automation Across Industry in LA County

SoCal Tech Calendar

Thursday, March 21, 2019 -- R.E.D Talk: Investment in Technology and Automation Across Industry in LA County. aking a closer look at how industries like transportation, aerospace, trade and logistics, manufacturing, and banking are adapting to new waves of technology and advancement in automation. See [link] (more

Invest 100

Cubic Acquires Nuvotronics


San Diego-based Cubic Corporation said late Thursday that it has acquired Nuvotrpnics , a provider of microfabricated radio frequency (RF) products, in a deal worth $64M in cash plus up to $8M in earn out. Nuvotronics is based in Durham, North Carolina. According to Cubic, the deal will help it enhance its Cubic Mission Solutions' portfolio.

TCVN's 2019 Investor Speed Dating

SoCal Tech Calendar

Thursday, March 21, 2019 --.

TCVN 100

Study: Cybersecurity Industry Growing In San Diego


A nonprofit organization focused on promoting cybersecurity and related jobs in San Diego, the Cyber Center of Excellence , says it has commissioned a study which has found that cybersecurity related jobs have grown in San Diego by 11 percent since 2016, with the industry generating $2.2 billion in GDP.

Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments


A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA.

Guide 74

More Trending

Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More


While all eyes in the biopharmaceutical world are currently trained on Bristol-Myers Squibb’s proposal to buy Celgene for $74 billion , it wasn’t that long ago that another company’s gaze was fixed on the Summit, NJ, drug maker. In the early 2000s, before the FDA approved Celgene’s flagship multiple myeloma drug lenalidomide (Revlimid), Novartis (NYSE: NVS considered buying the company. It passed, unwilling to risk billions on an unapproved drug.

Qualcomm Gets $31M in Patent Infringement Trial Win Over Apple


Wireless giant Qualcomm notched a win Friday in its ongoing multijurisdictional war with smartphone maker Apple as a federal jury in San Diego unanimously backed its patent infringement case. Qualcomm (NASDAQ: QCOM ) said Friday that the jury found that some versions of Apple’s iPhones—the 7, 7 Plus, 8, 8 Plus, and X—infringed two of its patents while the three newer models also infringed a third.